Two percent of all patients presenting to the Emergency Departments have complaints involving
the eye. Corneal abrasions are a common diagnosis with patients with eye pain and often cause
significant discomfort. Current treatment includes a thorough evaluation of the eye followed
by patching, empiric antibiotics, cycloplegics and oral pain medicines. This study will be a
randomized controlled trial to determine the safety and efficacy of BCLs. It will involve the
initial patient evaluation followed by a return visit to the Emergency Department within 36
hours for re-examination. At each visit, the patient will be assessed for the size and
location of the abrasion along with their report of pain using a visual analog scale. Data
will be recorded on a standard data collection sheet. Telephone contact will be made at 30
days to ensure resolution of abrasion and that no complications ensued.
Phase:
Phase 2
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center